Session 8: Primary systemic therapy of early breast cancer
Chairs: Eric Winer (USA), Giuseppe Curigliano (Italy)
- Primary systemic therapy for clinicians: Medical and research perspectives (Sybille Loibl, Germany)
- Neoadjuvant endocrine therapy: Patient selection, treatment duration and surrogate endpoints (Mitch Dowsett, United Kingdom)
- Clinical usefulness and relevance of intermediate endpoints for cytotoxic primary systemic therapy (Gunter von Minckwitz, Germany)
- Clinical trial designs in the neoadjuvant setting: Challenges of the genomic era (Lisa Carey, USA)
- Discussion